Tianxing Medical (01609) Hong Kong public offering received a subscription of 7823.13 times. The global offering raised approximately HK$7.584 billion.

date
22:59 04/05/2026
avatar
GMT Eight
Tianxing Medical (01609) announced the results of its placement, with a total of 8.4219 million H shares being globally offered. 10% of the shares were publicly offered in Hong Kong, while 90% were offered internationally. The offer price per share was 98.5 Hong Kong dollars, resulting in a net proceeds of approximately 758.4 million Hong Kong dollars from the global placement. Each lot consists of 50 shares, and it is expected that the H shares will begin trading on the Stock Exchange of Hong Kong at 9:00 am on Tuesday, May 5, 2026.
Tianxing Medical (01609) announced the results of its placement, with a total of 8.4219 million H shares sold globally. 10% of the shares were publicly sold in Hong Kong, while 90% were sold internationally. The sale price per share was HK$98.5, resulting in a net raise of approximately HK$758.4 million globally. Each lot consists of 50 shares, and it is expected that the H shares will begin trading on the Hong Kong Stock Exchange on May 5, 2026 (Tuesday) at 9:00 am. The public sale in Hong Kong was oversubscribed 7823.13 times, while the international sale was oversubscribed 10.41 times.